Viewing Study NCT05533892


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-05-15 @ 1:49 AM
Study NCT ID: NCT05533892
Status: RECRUITING
Last Update Posted: 2023-12-19
First Post: 2022-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
Sponsor: Wan-Guang Zhang
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2022-S038
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None UNKNOWN View
None INDUSTRY View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None INDUSTRY View
None INDUSTRY View